Breast Cancer
Contrast medium and air in MammoSite treatment caused dose perturbations
Published in Women's Health Weekly, October 20th, 2005
According to recent research from the United States, "In the management of early breast cancer, a partial breast irradiation technique called MammoSite (Proxima Therapeutic Inc., Alpharetta, GA) has been advocated in recent years. In MammoSite, a balloon implanted at the surgical cavity during tumor excision is filled with a radio-opaque solution, and radiation is delivered via a high dose rate brachytherapy source situated at the center of the balloon."
"Frequently air may be introduced during placement of the balloon and/or injection of the contrast solution into the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Connection between long-term weight change and breast cancer risk studied - Breast Cancer Diagnostics
Phase contrast imaging evaluated to improve lesion detectability - Diet & Nutrition
Mothers' milk analyzed, lipid kinase activity of antibodies defined - Malaria Risk Factors
Non- and semi-immune pregnant women and their fetuses are at risk for malaria - Sexually Transmitted Disease
Dating violence associated with STD/HIV in sexually active adolescents girls - Anorexia Nervosa
Multiple DRD2 polymorphisms associated with anorexia nervosa - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
